At Week 12, 13.3% of participants achieved UAS7 ≤ 6, 6.7% achieved complete remission (UAS7 = 0); however, these categorical improvements did not reach statistical significance.
← all excerpts
Clinical Efficacy and Safety of Intramuscular Injections of Autologous Total IgG in Patients With Chronic Spontaneous Urticaria: An Open-Label Prospective Pilot Trial.
1
—
—